Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV001783389 | SCV002024880 | pathogenic | not provided | 2019-03-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001885162 | SCV002231636 | pathogenic | GNE myopathy; Sialuria | 2022-02-02 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1323025). This variant has not been reported in the literature in individuals affected with GNE-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Ser273*) in the GNE gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GNE are known to be pathogenic (PMID: 24027297). |
Baylor Genetics | RCV003470905 | SCV004191651 | pathogenic | GNE myopathy | 2023-04-29 | criteria provided, single submitter | clinical testing |